COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Anargyros Kapetanakis et al.|Leukemia|2021Cited by 94
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Elżbieta Kalicińska, Mehreen Ali Khan et al.|EClinicalMedicine|2023Cited by 21
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Thomas Longval, Lydia Scarfò et al.|HemaSphere|2024Cited by 2
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLLThomas Chatzikonstantinou, Robert J. Kreitman, Lydia Scarfò et al.|Blood|2021Cited by 1